HELEN ZADOURIAN: Open Payments
NPI 1275980047 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 22 payments from 12 companies in 2025. Trend: 2023 $403 · 2024 $147 · 2025 $682
Food & beverage: $483Education: $199
| Company | Payments | Amount |
|---|---|---|
| Caris MPI, Inc. | 4 | $107 |
| Astellas Pharma US Inc | 1 | $100 |
| SEAGEN INC. | 1 | $99 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| Merck Sharp & Dohme LLC | 2 | $69 |
| PFIZER INC. | 4 | $61 |
| Eisai Inc. | 2 | $49 |
| ABBVIE INC. | 1 | $28 |
| Verastem, Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: MI CANCER SEEK, MYFEMBREE, KEYTRUDA, TIVDAK, Lenvima, ELAHERE, AVMAPKI FAKZYNJA CO-PACK, JEMPERLI.
Industry payments across CA — which companies pay providers there.
